Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Betaferon Prospective Study on Adherence, Coping and Nursing Support.

Next Previous
Trial Profile

Betaferon Prospective Study on Adherence, Coping and Nursing Support.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms BEACON
  • Sponsors Bayer

Most Recent Events

  • 20 Jan 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
  • 28 Oct 2013 Planned end date changed from 1 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
  • 01 Aug 2013 Planned number of patients changed from 1500 to 1722 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top